Skip to main content
Novacyt logo

Novacyt — Investor Relations & Filings

Ticker · ALNOV ISIN · FR0010397232 LEI · 213800BWAC2BF295EG28 PA Manufacturing
Open in API
Filings indexed 1,101 across all filing types
Latest filing 2023-09-28 Interim / Quarterly Rep…
Country FR France
Listing PA ALNOV

About Novacyt

https://novacyt.com/

Novacyt is an international molecular diagnostics company that provides a broad portfolio of integrated technologies and services. The company's core activities include the design, development, manufacturing, and commercialization of in vitro and molecular diagnostic tests, with a specialization in real-time PCR (qPCR) kits and reagents. Novacyt's solutions are applied across various markets, including clinical diagnostics for human health, with a focus on infectious diseases and oncology, as well as animal health and food safety. The company also offers custom development services, contract manufacturing, and pharmaceutical research services such as whole genome sequencing.

Recent filings

Filing Released Lang Actions
Résultats intermédiaires 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Résultats intermédiaires 2023' (Interim Results 2023) for Novacyt S.A. It provides a comprehensive overview of the company's financial performance for the six-month period ending June 30, 2023, including detailed financial highlights (revenue, EBITDA, net loss, cash position) and operational updates. It is not a mere announcement of a report, but the report itself, containing substantive financial data and management commentary. Therefore, it is classified as an Interim/Quarterly Report. H1 2023
2023-09-28 French
Half Year 2023 Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled '2023 Interim Results' and contains detailed financial information, including an income statement for H1 2023, strategic business updates, and management profiles. It is clearly a presentation deck for investors, as evidenced by the extensive legal disclaimers regarding financial promotions, forward-looking statements, and the presence of presenter biographies. Since it provides a comprehensive overview of the company's interim financial performance and strategy, it is classified as an Investor Presentation. H1 2023
2023-09-28 English
Rappel aux actionnaires concernant le vote à l'Assemblée Générale des Actionnaires
Proxy Solicitation & Information Statement Classification · 98% confidence The document is titled "Rappel aux actionnaires concernant le vote à l'Assemblée Générale des Actionnaires" (Shareholder reminder concerning the vote at the General Shareholders' Meeting) and explicitly mentions the upcoming Annual General Meeting ('l'Assemblée'). It details voting procedures, quorum requirements, and deadlines for submitting votes in advance of the meeting scheduled for October 5, 2023. This content is directly related to soliciting shareholder participation and providing information ahead of the AGM, which aligns perfectly with the definition of Proxy Solicitation & Information Statement (PSI). While it relates to the AGM, it is focused on the voting process and materials leading up to it, rather than being the AGM presentation itself (AGM-R) or the formal notice of the meeting (DEF 14A often covers compensation, which is not the primary focus here). Since it is a detailed guide on how to vote and register for the meeting, PSI is the most accurate classification.
2023-09-28 French
AGM voting
AGM Information Classification · 98% confidence The document is an official announcement filed under RNS Number 3619M, dated September 14, 2023. The primary subject is the announcement that shareholders can now vote for the rescheduled Annual General Meeting ("AGM") scheduled for October 5, 2023. It details the procedures for voting in advance and attending the virtual meeting. Since the document is an announcement regarding the logistics, voting procedures, and materials for the AGM, it directly relates to the AGM process. The most specific category is 'AGM Information' (AGM-R). Although it is distributed via RNS, the content is highly specific to the AGM, making AGM-R the superior classification over the general RNS fallback.
2023-09-14 English
Vote à l'Assemblée Générale Annuelle (AGA)
AGM Information Classification · 99% confidence The document is explicitly titled "Vote à l'Assemblée Générale Annuelle (AGA)" (Vote at the Annual General Meeting (AGM)) and details the procedures, dates (October 5, 2023), and methods for shareholders to vote for the upcoming AGM. It discusses resolutions, quorum requirements, and proxy voting instructions. This content directly relates to the materials and announcements surrounding the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). It is not a general regulatory filing (RNS) because it is highly specific to the AGM process.
2023-09-14 French
TEXTE DES RESOLUTIONS
AGM Information Classification · 99% confidence The document text explicitly details the 'TEXTE DES RESOLUTIONS' (Text of Resolutions) for a general meeting, divided into 'ASSEMBLEE GENERALE ORDINAIRE' (Ordinary General Meeting) and 'ASSEMBLEE GENERALE EXTRAORDINAIRE' (Extraordinary General Meeting). Key items include the approval of annual accounts (for the year ended December 31, 2022), allocation of results, authorization for share repurchase (Resolution 6), ratification of board appointments, and various delegations concerning capital increases and share issuance. These elements are characteristic of materials presented and voted upon during an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R.
2023-09-14 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.